• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Horwitz, S
    O'Connor, O
    Pro, B
    Illidge, Timothy M
    Fanale, M
    Advani, R
    Bartlett, N
    Christensen, J
    Morschhauser, F
    Domingo-Domenech, E
    Rossi, G
    Kim, W
    Feldman, T
    Lennard, A
    Belada, D
    Illes, A
    Tobinai, K
    Tsukasaki, K
    Yeh, S
    Shustov, A
    Huttmann, A
    Savage, K
    Yuen, S
    Iyer, S
    Zinzani, P
    Hua, Z
    Little, M
    Rao, S
    Woolery, J
    Manley, T
    Trumper, L
    Aboulafia, D
    Alpdogan, O
    Ando, K
    Arcaini, L
    Baldini, L
    Bellam, N
    Bartlett, N
    Yehuda, DB
    Benedetti, F
    Borchman, P
    Bordessoule, D
    Brice, P
    Briones, J
    Caballero, D
    Carella, A
    Chang, H
    Cheong, J
    Cho, S
    Choi, I
    Choquet, S
    Colita, A
    Congui, A
    D'amore, F
    Dang, N
    Davison, K
    De, Guibert S
    Brown, P
    Delwail, V
    Demeter, J
    di Raimondo, F
    Do, Y
    Domingo, E
    Douvas, M
    Dreyling, M
    Ernst, T
    Fay, K
    Ferrero, S
    Flinn, I
    Forero-Torres, A
    Fox, C
    Friedberg, J
    Fukuhara, N
    Garcia-Marco, J
    Cruz, J
    Codina, J
    Gressin, R
    Grigg, A
    Gurion, R
    Haioun, C
    Hajek, R
    Hanel, M
    Hatake, K
    Hensen, R
    Horowitz, N
    Huttmann, A
    Ishizawa, K
    Islas-Ohlmayer, M
    Jacobsen, E
    Janakiram, M
    Jurczak, W
    Kaminski, M
    Kato, K
    Kirgner, I
    Kuo, C
    Lazaroiu, M
    Le, Du, K
    Lee, J
    Legouill, S
    Larosee, P
    Levi, I
    Link, B
    Maisonneuve, H
    Maruyama, D
    Mayer, J
    McCarty, J
    Mckay, P
    Minami, Y
    Mocikova, H
    Morra, E
    Munoz, J
    Nagai, H
    O'Connor, O
    Opat, S
    Pettengell, R
    Pezzutto, A
    Pfreundschuh, M
    Pluta, A
    Porcu, P
    Quach, H
    Rambaldi, A
    Renwick, W
    Reyes, R
    Izquierdo, A
    Ruan, J
    Rusconi, C
    Salles, G
    Santoro, A
    Sarriera, J
    Savage, K
    Shibayama, H
    Suh, C
    Sureda, A
    Tanimoto, M
    Taniwaki, M
    Tilly, H
    Trneny, M
    Trumper, L
    Tsukamoto, N
    Vitolo, U
    Walewski, J
    Weidmann, E
    Wilhelm, M
    Witzens-Harig, M
    Yacoub, A
    Yamamoto, K
    Yoon, S
    Yun, H
    Zain, J
    Zinzan, P
    Show allShow less
    Affiliation
    Memorial Sloan Kettering Cancer Center, New York
    Issue Date
    2019
    
    Metadata
    Show full item record
    Citation
    Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, et al. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet. 2019 Jan 19;393(10168):229-40.
    Journal
    Lancet
    URI
    http://hdl.handle.net/10541/621583
    DOI
    10.1016/S0140-6736(18)32984-2
    PubMed ID
    30522922
    Additional Links
    https://dx.doi.org/10.1016/S0140-6736(18)32984-2
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1016/S0140-6736(18)32984-2
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study.
    • Authors: Fanale MA, Horwitz SM, Forero-Torres A, Bartlett NL, Advani RH, Pro B, Chen RW, Davies A, Illidge T, Huebner D, Kennedy DA, Shustov AR
    • Issue date: 2014 Oct 1
    • The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma.
    • Authors: Horwitz S, O'Connor OA, Pro B, Trümper L, Iyer S, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Menne T, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Zinzani PL, Miao H, Bunn V, Fenton K, Fanale M, Puhlmann M, Illidge T
    • Issue date: 2022 Mar
    • Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study.
    • Authors: Herrera AF, Zain J, Savage KJ, Feldman T, Brammer JE, Chen L, Puverel S, Popplewell L, Budde LE, Mei M, Hosing C, Nair R, Leslie L, Daniels S, Peters L, Forman S, Rosen S, Kwak L, Iyer SP
    • Issue date: 2024 Sep
    • Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
    • Authors: Eichenauer DA, Plütschow A, Kreissl S, Sökler M, Hellmuth JC, Meissner J, Mathas S, Topp MS, Behringer K, Klapper W, Kuhnert G, Dietlein M, Kobe C, Fuchs M, Diehl V, Engert A, Borchmann P
    • Issue date: 2017 Dec
    • Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial.
    • Authors: Straus DJ, Długosz-Danecka M, Connors JM, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Ramchandren R, Zinzani PL, Hutchings M, Munoz J, Lee HJ, Kim WS, Advani R, Ansell SM, Younes A, Gallamini A, Liu R, Little M, Fenton K, Fanale M, Radford J
    • Issue date: 2021 Jun
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.